Insulin Lispro

• Insulin lispro is a rapid‑acting insulin analog used to manage blood glucose in diabetes mellitus.
• Type 1 diabetes mellitus: provides mealtime glucose control and reduces post‑prandial spikes.
• Type 2 diabetes mellitus: used as part of intensive insulin regimens to improve post‑prandial glycaemia.

• Insulin lispro binds to the insulin receptor on target cells, rapidly activating the receptor’s tyrosine kinase activity. This promotes translocation of GLUT‑4 transporters to the cell membrane, increasing glucose uptake in muscle and adipose tissue, while suppressing hepatic glucose production. Its altered amino‑acid sequence confers a faster onset and shorter duration compared with regular human insulin.

Insulin lispro may cause a range of adverse reactions.

Common Side Effects

• Hypoglycemia: low blood glucose episodes, especially if meals are missed or dosing is excessive.
• Injection site pain or erythema: mild discomfort at the injection site.
• Lipodystrophy: localized changes in subcutaneous fat with repeated injections.
• Weight gain: modest increase associated with improved glycaemic control.
• Mild allergic reactions: localized itching or rash.

Serious or Rare Side Effects

• Severe hypoglycemia: neurological impairment requiring assistance.
• Anaphylaxis: acute, potentially life‑threatening allergic reaction.
• Hypokalemia: low serum potassium levels, particularly with high insulin doses.
• Edema: fluid retention, especially in patients with cardiac or renal disease.
• Serum sickness‑like reaction: fever, arthralgia, and rash.

• When using Insulin lispro, consider the following precautions.
• Dose adjustment: tailor the dose based on frequent blood‑glucose monitoring and meal patterns.
• Renal impairment: monitor closely as reduced clearance may increase hypoglycemia risk.
• Pregnancy: use only if the anticipated benefit justifies potential risk to the fetus.
• Alcohol consumption: may potentiate hypoglycemia; advise patients to limit intake.
• Driving or operating machinery: ensure glucose is within safe range before engaging in such activities.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Insulin lispro can interact with several medications, requiring vigilance.

Major Interactions (Avoid)

• Beta‑blockers: may mask hypoglycemia symptoms, delaying recognition.
• Monoamine oxidase inhibitors (MAOIs): can potentiate insulin’s glucose‑lowering effect.
• Alcohol: enhances risk of severe hypoglycemia, especially with rapid‑acting insulins.

Moderate Interactions (Monitor Closely)

• Thiazide diuretics: may increase blood glucose, necessitating dose adjustments.
• Corticosteroids: can raise glucose levels, potentially requiring higher insulin doses.
• Oral contraceptives: may alter insulin requirements, warranting closer monitoring.